Pectoral muscle hematoma as a complication of Covid-19 treatment: A Case Report

Yıl 2021, Cilt: 3 Sayı: Supplement 1, 79 - 81, 07.03.2021

Yıldız Okuturlar Damla Gürleyik Nur Ramoğlu Yasemin Gündoğdu İftihar Köksal

https://doi.org/10.46310/tjim.876970

Cited By: 1

Öz

In COVID-19 disease, the activation of the coagulation system is increasing. Here we presented a case of COVID-19 who developed a hematoma in the pectoral muscle possibly associated with anticoagulation therapy.

Anahtar Kelimeler

COVID-19, bleeding, anticoagulation, coagulopathy

Kaynakça

• Frydman, G. H., Streiff, M. B., Connors, J. M., & Piazza, G. The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents. 2020; TH Open, 04(04), e288–e299. doi:10.1055/s-0040-1718415
• Unuvar A. COVID-19 and Coagulopathy. Sağlık Bilimlerinde İleri Araştırmalar Dergisi 2020; 3(Suppl.1): S53-S62. https://doi.org/10.26650/JARHS2020-S1-0007
• Cuker, Adam, and Flora Peyvandi. “Coronavirus Disease 2019 (COVID-19): Hypercoagulability.” UpToDate, 2020, www.uptodate.com/contents/coronavirus-disease-2019-covid-19-hypercoagulability.